Cassava Sciences- Warrants (15/11/2024) Total Current Liabilities

Cassava Sciences- Warrants (15/11/2024) (SAVAW) currently reports a total current liabilities of $40M as of June 2026. That compares with $47M in the prior-year period — down 15.2% year over year. Use the charts on this page to explore Cassava Sciences- Warrants (15/11/2024)'s total current liabilities history and peer comparisons.

Cassava Sciences- Warrants (15/11/2024)'s total current liabilities decreased from $47M to $40M — a 15.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cassava Sciences- Warrants (15/11/2024) reported $40M in total current liabilities as of June 2026. That compares with $47M in the prior-year period — down 15.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $40M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cassava Sciences- Warrants (15/11/2024), and consider following SAVAW for alerts when major investors trade the stock.

Cassava Sciences- Warrants (15/11/2024) is classified in the Healthcare sector. On total current liabilities, it currently shows $40M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SAVAW with unrelated industries.